| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.91.4.941 |
| P698 | PubMed publication ID | 7850978 |
| P2093 | author name string | A M Zeiher | |
| V Schächinger | |||
| H Goebel | |||
| C Ihling | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | unstable angina | Q2032041 |
| P304 | page(s) | 941-947 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina | |
| P478 | volume | 91 |
| Q42174542 | A combination of experimental and numerical methods to investigate the role of strain rate on the mechanical properties and collagen fiber orientations of the healthy and atherosclerotic human coronary arteries |
| Q51282783 | An exaggerated blood pressure response to exercise is associated with nitric oxide bioavailability and inflammatory markers in normotensive females. |
| Q93150619 | Association between circulating big endothelin-1 and noncalcified or mixed coronary atherosclerotic plaques |
| Q35017010 | Autonomic contribution to endothelin-1 increase during laboratory anger-recall stress in patients with coronary artery disease |
| Q43013486 | C reactive protein and microvascular function |
| Q78106216 | Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina |
| Q35843056 | Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort |
| Q94561912 | Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity |
| Q73453181 | Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina |
| Q33175630 | Coronary spasm--a clinically relevant problem? |
| Q34468833 | Depression Predicts Elevated Endothelin-1 in Patients With Coronary Artery Disease |
| Q77295581 | Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Coronary Artery Disease Research Group |
| Q41349623 | Endothelial dysfunction and hypertension. |
| Q37878811 | Endothelial dysfunction--assessment of current status and approaches to therapy |
| Q41211992 | Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon? |
| Q34304701 | Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched? |
| Q28584822 | Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice |
| Q34028145 | Endothelin in cardiovascular control: the role of endothelin antagonists |
| Q34028140 | Endothelin in heart failure. |
| Q34289891 | Endothelin receptor antagonists and cardiovascular diseases of aging |
| Q34246867 | Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? |
| Q35028439 | Endothelin receptor expression and pharmacology in human saphenous vein graft |
| Q35027611 | Endothelin receptor subtypes and their functional relevance in human small coronary arteries |
| Q74446244 | Endothelin-1 and unstable angina: effect of either endothelin ET(A) or ET(B) receptor antagonism in a locally injured canine coronary artery |
| Q71778334 | Endothelin-1 expression in vein graft stenosis |
| Q33892724 | Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression |
| Q73308449 | Endothelin-1 is involved in the growth promotion of vascular smooth muscle cells by hyaluronic acid |
| Q73682855 | Endothelin-1 peptide expression in transplant coronary artery disease |
| Q33941507 | Endothelin-1 production by the canine macrophage cell line DH82: enhanced production in response to microbial challenge |
| Q71447011 | Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1 |
| Q43833305 | Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. |
| Q41843668 | Further evidence for a role of endothelin-1 (ET-1) in critical limb ischaemia |
| Q53599255 | Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients. |
| Q36040759 | HIV-1, reactive oxygen species, and vascular complications |
| Q77155885 | Impact of neuroendocrine activation on coronary artery disease |
| Q44413495 | Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation |
| Q72992401 | Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis |
| Q35028042 | Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. |
| Q77654153 | Increased tissue endothelin-1-like immunoreactivity in the internal mammary artery of patients with diabetes or hypercholesterolemia modulates the graft flow in the peri-operative period |
| Q73390807 | Increases of vascular endothelin-converting enzyme activity and endothelin-1 level on atherosclerotic lesions in hyperlipidemic rabbits |
| Q37871076 | Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study |
| Q34179077 | Is reversal of endothelial dysfunction still an attractive target in modern cardiology? |
| Q37683992 | Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis |
| Q44588472 | Mechanisms of 17beta-estradiol on the production of ET-1 in ovariectomized rats |
| Q36385620 | Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice |
| Q77386469 | Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris |
| Q71129084 | Pathophysiology of coronary artery disease |
| Q77589997 | Plasma levels and vascular effects of endothelin and big endothelin in patients with stable and unstable angina pectoris undergoing coronary bypass grafting |
| Q98159169 | Protective Activities of Dendrobium huoshanense C. Z. Tang et S. J. Cheng Polysaccharide against High-Cholesterol Diet-Induced Atherosclerosis in Zebrafish |
| Q26865564 | Reactive oxygen species-activated nanomaterials as theranostic agents |
| Q64897511 | Role of endothelin as a mitogen in experimental glomerulonephritis in rats. |
| Q41593796 | Role of inflammation in the pathogenesis of unstable coronary artery disease. |
| Q34613688 | Severe depressive symptoms are associated with elevated endothelin-1 in younger patients with acute coronary syndrome |
| Q40801550 | Specificity of glycosaminoglycan suppression of endothelin-1 production by human umbilical vein endothelial cells |
| Q33857649 | Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery disease |
| Q41064358 | The clinical potential of endothelin receptor antagonists in cardiovascular medicine. |
| Q36869570 | The effects of xuefu zhuyu and shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial. |
| Q41290159 | The endothelin system and its potential as a therapeutic target in cardiovascular disease. |
| Q55026371 | The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization. |
| Q34317655 | The therapeutic potential of endothelin receptor antagonists in cardiovascular disease. |
| Q40925433 | Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies |
| Q73298197 | [Endothelial dysfunction in patients with acute coronary syndrome] |
| Q78089583 | [Endothelin-1 and cardiovascular diseases] |
| Q74564754 | [Pathomorphology of coronary atherosclerosis] |
| Q74564766 | [The role of endothelial function for ischemic manifestations of coronary atherosclerosis] |
Search more.